Skip to content

Clinical trials

Completed Lymphoma, Large B-Cell, Diffuse trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large B-Cell, Diffuse Status: Completed Country / region: Netherlands Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20042
20101
20123
20132
20141
20154
20161
20172
20183
20192

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene4
Novartis Pharmaceuticals4
European Organisation for Research and Treatment of Cancer - EORTC3
Hoffmann-La Roche2
Kite, A Gilead Company2
AbbVie1
Amgen1
Children's Oncology Group1
Commissie Voor Klinisch Toegepast Onderzoek1
Genentech, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large B-Cell, Diffuse25
Lymphoma, Non-Hodgkin9
Lymphoma8
Lymphoma, Follicular7
Recurrence7
Burkitt Lymphoma4
Lymphoma, B-Cell4
Hodgkin Disease3
Immunoblastic Lymphadenopathy3
Neoplasms3

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.